No hay productos en el carrito



Melanoma. Molecular Biology, Risk Factors & Treatment Options (Cancer Etiology, Diagnosis & Treatments Series)
Jones, A.C.
1ª Edición Septiembre 2013
Inglés
Tapa dura
267 pags
626 gr
18 x 26 x null cm
ISBN 9781628086089
Editorial NOVA SCIENCE PUBLISHERS INC. U.S.
LIBRO IMPRESO
-5%
164,99 €156,74 €IVA incluido
158,64 €150,71 €IVA no incluido
Recíbelo en un plazo de
2 - 3 semanas
Description
Melanoma accounts for only 4% of all skin cancer cases but most of skin cancer-related death. The rising incidence of melanoma makes this tumour an important public health problem. In this book, the authors present current research in the study of the molecular biology, risk factors and treatment options for melanoma. Topics include the role of P13K/AKT and Wnt/ß-Catenin pathways in melanoma's progression to metastatic disease; cutaneous melanoma; molecular determinants of melanoma vasculogenic mimicry; new aspects of the molecular biology of melanoma metastasis; the surgical extent of regional lymph node dissection for cutaneous melanoma and its novel techniques and modifications; the epidemiology of melanoma in young individuals; cardiac involvement in malignant melanoma; poor Karnofsky performance status and high serum lactate dehydrogenase level identifies patients with brain metastases from malignant melanoma who do not benefit from palliative whole brain radiotherapy; interferon-beta therapy; and boron neutron capture therapy.
Table of Contents
Preface; Melanoma Progression to Metastatic Disease: The Role of the PI3K/AKT & Wnt/ß-Catenin Pathways; Cutaneous Melanoma: Molecular Biology, Risk Factors & Treatment Options; Molecular Determinants of Melanoma Vasculogenic Mimicry; New Aspects of the Molecular Biology of Melanoma Metastasis; The Surgical Extent of Regional Lymph Node Dissection for Cutaneous Melanoma & its Novel Techniques & Modifications; Cutaneous Melanoma: Molecular Mechanisms & Current Therapeutic Approaches; Epidemiology of Melanoma in Young Individuals: A Systematic Review; Cardiac Involvement in Malignant Melanoma; Poor Karnofsky Performance Status & High Serum Lactate Dehydrogenase Level (KPS/LDH Index) Identifies Patients with Brain Metastases from Malignant Melanoma who do not Benefit from Palliative Whole Brain Radiotherapy; Short Communication: Interferon-Beta Therapy for Melanoma: A Review of the Literature; Molecular Targeted Therapy & Drug Resistance; Boron Neutron Capture Therapy for Melanoma Treatment; Index.
© 2025 Axón Librería S.L.
2.149.0